Table 4.
Pre-post changes in primary and secondary outcomes
| Time – Mean (SD) | |||||
|---|---|---|---|---|---|
| Baseline | 12 weeks | Diff (95% CI) | d | p | |
| Person Variables | |||||
| KiKS | 17.0 (5.0) | 20.7 (3.8) | 3.7 (2.7–4.8) | 0.8 | <.001 |
| Understanding of Physical Activity Guidelines | 16.4 (2.5) | 17.2 (2.3) | 0.9 (0.1–1.6) | 0.4 | .02 |
| Self-Efficacy | |||||
| SEMCD-6 | 6.7 (2.1) | 7.44 (1.9) | 0.8 (0.3–1.2) | 0.4 | <.01 |
| Emotional Distress/Self-Appraisal | |||||
| DASS-21 | |||||
| Depressionab | 4.2c (4.1d) | 3.0c (3.3d) | 1.2 (0.1–2.1) | 0.3e | .03 |
| Anxietyab | 4.6c (4.1d) | 4.4c (4.1d) | 0.2 (−0.91–1.3) | 0.1e | .70 |
| Stressab | 5.7c (4.2d) | 4.5c (3.6d) | 1.2 (0.3–2.1) | 0.3e | .01 |
| Behaviour | |||||
| Aus.CKD-SM | 47.0 (8.7) | 53.2 (7.5) | 6.2 (4.5–7.9) | 0.8 | <.001 |
| Self-Integration | 13.7 (3.3) | 15.8 (2.9) | 2.2 (1.5–2.9) | 0.7 | <.001 |
| Seeking Support | 8.3 (2.7) | 9.2 (2.7) | 1.0 (0.4–1.5) | 0.4 | <.001 |
| Adherence to Lifestyle Modifications | 12.4 (2.8) | 13.7 (2.7) | 1.4 (0.8–2.0) | 0.5 | <.001 |
| Problem-Solving | 12.7 (2.7) | 14.4 (2.1) | 1.7 (1.1–2.3) | 0.7 | <.001 |
| HAP | |||||
| Maximum Activity Score | 69.2 (15.6) | 72.0 (14.8) | 2.8 (0.6–5.0) | 0.2 | .01 |
| Adjusted Activity Score | 59.4 (21.5) | 62.4 (19.3) | 3.0 (0.6–5.3) | 0.2 | .02 |
| Self-care | 7.5 (1.6) | 7.5 (1.5) | < 0.1 (−0.2–0.2) | < 0.1 | .89 |
| Personal/Household Work | 18.7 (6.6) | 19.4 (5.9) | 0.7 (− < 0.1–1.5) | 0.1 | .06 |
| Entertainment/Social | 9.5 (2.8) | 10.0 (2.6) | 0.5 (< 0.1–0.9) | 0.2 | .04 |
| Independent Exercise | 8.0 (6.5) | 9.2 (6.8) | 1.2 (0.1–2.2) | 0.2 | .04 |
| AUDIT-C | 2.4 (2.7) | 2.0 (2.3) | 0.3 (0.1–0.6) | 0.1 | .01 |
| Fruit and Vegetables Consumed Yesterdaya | 2.3 (1.5) | 6.3 (3.0) | 4.0 (3.3–4.8) | 1.7 | <.001 |
| Communication with HCPsf | 13.4 (2.9) | 14.3 (2.3) | 0.7 (0.2–1.6) | 0.3 | .01 |
| Cigarettes per day (n = 4) | 16.3 (4.8) | 16.3 (4.8) | 0.0 (−6.5–6.5) | < 0.001 | .99 |
| Outcomes | |||||
| eGFR (n = 46) | 55.2 (24.1) | 51.3 (24.2) | 3.9 (1.0–6.9) | 0.7 | .01 |
| BP (n = 39) 88.5% at target (T0 and T1) | |||||
| Systolic | 129.6 (23.3) | 120.7 (15.8) | 8.9 (2.9–14.9) | 0.7 | <.01 |
| Diastolic | 74.8 (11.1) | 70.5 (9.6) | 4.3 (0.9–7.8) | 0.6 | .01 |
| SF12 | |||||
| PCS | 41.3 (11.1) | 44.5 (8.7) | 3.2 (0.9–5.4) | 0.3 | .01 |
| MCS | 51.9 (9.8) | 50.9 (9.6) | −1.1 (−3.8–1.6) | 0.1 | .43 |
| Weight (n = 37) | 87.4 (30.6) | 87.8 (30.6) | −0.4 (−1.1–0.4) | 0.3 | .32 |
SD standard deviation, Diff mean difference, CI confidence interval
d = Effect size (small ≥0.2; medium ≥0.5; large ≥0.8 [40])
an = 56
bWilcoxon Signed-Rank test results reported to deal with effects of violations of t-test assumptions
cMedian
dIQR
er = Effect size (small ≥0.1; medium ≥0.3; large ≥0.5 [40])
fn = 65